Results 11 to 20 of about 35,774 (303)

Measuring the health benefits and costs of antimicrobial-resistant gonorrhea surveillance in the United States: an agent-based model and cost-effectiveness analysisResearch in context [PDF]

The Lancet Regional Health. Americas
Summary: Background: Antimicrobial resistant (AMR) gonorrhea poses an increasing threat to public health, yet evidence on the cost-effectiveness of surveillance systems that inform treatment policy is lacking. We assessed the long-term, population-level
Marcy S. Ekanayake-Weber, Minttu M. Rönn, Xuecheng Yin, Katherine Hsu, Yunfei Li, Thomas L. Gift, Harrell Chesson, Rebekah Frankson, Joshua A. Salomon, Yonatan H. Grad, Reza Yaesoubi   +10 more
doaj   +2 more sources

Socioeconomic factors associated with chlamydia and gonorrhea positivity in the United States, 2022–2024 [PDF]

BMC Public Health
Background Socioeconomic factors (SEF) can be associated with health outcomes. Understanding the relationships among SEF, demographics, and sexually transmitted infection (STI) positivity can help identify areas to improve STI prevention and care with ...
Larry He, Chirag G. Patel, Yamir Salabarría-Peña, Guoyu Tao   +3 more
doaj   +2 more sources

A Standards-Based, Cloud-Hosted CDS System for Gonorrhea Treatment and HIV Screening. [PDF]

Learn Health Syst
ABSTRACT Objective Neisseria gonorrhoeae (or gonococcus, GC) infections have increased in incidence and antibiotic resistance, prompting updates to management guidelines. Additionally, patients with recent GC infections have been identified as a target population for human immunodeficiency virus (HIV) screening and prevention. With the rapidly changing
Shenvi E, Boxwala A, Shaw S, Berro A, Karki S, Pooser M, Yang JE, Dumitru G, Ocampo J, Tailor A, Kanjilal S, Paredes C, Hao R, Kashyap N, Liebovitz D, Pérez A.   +15 more
europepmc   +2 more sources

Stably high azithromycin resistance and decreasing ceftriaxone susceptibility in Neisseria gonorrhoeae in 25 European countries, 2016

BMC Infectious Diseases, 2018
Background The European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP) performs annual sentinel surveillance of Neisseria gonorrhoeae susceptibility to therapeutically relevant antimicrobials across the European Union/European Economic Area (
Michaela J. Day, Gianfranco Spiteri, Susanne Jacobsson, Neil Woodford, Andrew J. Amato-Gauci, Michelle J. Cole, Magnus Unemo, Euro-GASP network   +7 more
doaj   +1 more source

Interruption time series analysis using autoregressive integrated moving average model: evaluating the impact of COVID-19 on the epidemic trend of gonorrhea in China

BMC Public Health, 2023
Background Interrupted time series (ITS) analysis is a growing method for assessing intervention impacts on diseases. However, it remains unstudied how the COVID-19 outbreak impacts gonorrhea.
Yanyan Li, Xingyan Liu, Xinxiao Li, Chenlu Xue, Bingjie Zhang, Yongbin Wang   +5 more
doaj   +1 more source

Ciprofloxacin Resistance and Gonorrhea Incidence Rates in 17 Cities, United States, 1991–2006

Emerging Infectious Diseases, 2014
Antimicrobial drug resistance can hinder gonorrhea prevention and control efforts. In this study, we analyzed historical ciprofloxacin resistance data and gonorrhea incidence data to examine the possible effect of antimicrobial drug resistance on ...
Harrell W. Chesson, Robert D. Kirkcaldy, Thomas L. Gift, Kwame Owusu-Edusei, Hillard S. Weinstock   +4 more
doaj   +1 more source

Oropharyngeal Gonorrhea in Absence of Urogenital Gonorrhea in Sexual Network of Male and Female Participants, Australia, 2018

Emerging Infectious Diseases, 2019
We describe a sexual network consisting of 1 nonbinary-gendered participant and 2 male and 4 female participants in Australia, 2018. Six of 7 participants had oropharyngeal gonorrhea in the absence of urogenital gonorrhea. This observation supports a new
Vincent J. Cornelisse, Catriona S. Bradshaw, Eric P.F. Chow, Deborah A. Williamson, Christopher K. Fairley   +4 more
doaj   +1 more source

Rifampicin Resistance Associated with rpoB Mutations in Neisseria gonorrhoeae Clinical Strains Isolated in Austria, 2016 to 2020

Microbiology Spectrum, 2022
Due to increasing rates of antimicrobial resistance (AMR) in Neisseria gonorrhoeae, alternative treatments should be considered. To assess rifampicin’s potential as a gonorrhea treatment, we used rpoB mutations to estimate rifampicin resistance in ...
Justine Schaeffer, Kathrin Lippert, Sonja Pleininger, Anna Stöger, Petra Hasenberger, Silke Stadlbauer, Florian Heger, Angelika Eigentler, Alexandra Geusau, Alexander Indra, Franz Allerberger, Werner Ruppitsch   +11 more
doaj   +1 more source

Gonorrhea: Tragic Effects on Women ​ [PDF]

, 2023
Gonorrhea is a sexually transmitted infection. In the United States, women have a higher rate of being affected with gonorrhea than men. It\u27s also more common for women that are the ages of 24 and younger that are being affected with gonorrhea.
Thompson, Aleah
core   +1 more source

Disseminated Gonorrhea

Clinical Practice and Cases in Emergency Medicine, 2020
Sexually transmitted infections have risen sharply over the last decade in the United States. The incidence of gonorrhea has risen to 172 reported cases per 100,000 people over the past year.
Janelle Estrada, Shane Sergent, John Ashurst   +2 more
doaj   +1 more source